BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11916095)

  • 1. Method comparison of flow cytometric assay of platelet microparticles and changes of platelet microparticles during cancer chemotherapy.
    Kim HK; Song KS; Park YS; Kim CM; Lee KR
    Thromb Haemost; 2002 Mar; 87(3):547-8. PubMed ID: 11916095
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advancement of platelet activation measurement: focusing on platelet-derived microparticle measurement].
    Hayasaka K; Moriyama T; Chiba H; Matsuno K
    Rinsho Byori; 2006 Mar; 54(3):250-5. PubMed ID: 16637573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a time-resolved immunofluorometric assay for quantifying platelet-derived microparticles in human plasma.
    Michelsen AE; Wergeland R; Stokke O; Brosstad F
    Thromb Res; 2006; 117(6):705-11. PubMed ID: 15990159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation.
    Goodall AH; Appleby J
    Methods Mol Biol; 2004; 272():225-53. PubMed ID: 15226548
    [No Abstract]   [Full Text] [Related]  

  • 6. Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans.
    Lubsczyk B; Kollars M; Hron G; Kyrle PA; Weltermann A; Gartner V
    Eur J Clin Invest; 2010 Jun; 40(6):477-82. PubMed ID: 20456486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reliable plasma marker of platelet activation: does it exist?
    Gurney D; Lip GY; Blann AD
    Am J Hematol; 2002 Jun; 70(2):139-44. PubMed ID: 12111787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations.
    Kim HK; Song KS; Lee ES; Lee YJ; Park YS; Lee KR; Lee SN
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):393-7. PubMed ID: 12138366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
    Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
    Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of activated platelets in canine blood by use of flow cytometry.
    Wills TB; Wardrop KJ; Meyers KM
    Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome.
    Arteaga RB; Chirinos JA; Soriano AO; Jy W; Horstman L; Jimenez JJ; Mendez A; Ferreira A; de Marchena E; Ahn YS
    Am J Cardiol; 2006 Jul; 98(1):70-4. PubMed ID: 16784924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for systemic platelet activation during or after orthotopic liver transplantation.
    Pereboom IT; Adelmeijer J; van Leeuwen Y; Hendriks HG; Porte RJ; Lisman T
    Liver Transpl; 2009 Aug; 15(8):956-62. PubMed ID: 19642138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
    Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I
    Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma markers of platelet and polymorphonuclear leukocyte activation in young adults with acute myocardial infarction.
    Caimi G; Hoffmann E; Montana M; Incalcaterra E; Dispensa F; D'Amico T; Canino B; Lo Presti R
    Clin Hemorheol Microcirc; 2005; 32(1):67-74. PubMed ID: 15665428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
    Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
    Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of in vitro-generated platelet microparticles using a modified flow cytometric strategy.
    Tocchetti EV; Flower RL; Lloyd JV
    Thromb Res; 2001 Jul; 103(1):47-55. PubMed ID: 11434945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation markers in long-term follow-up of young subjects with acute myocardial infarction.
    Lo Presti R; D'Amico T; Montana M; Canino B; Romano A; Caimi G
    Clin Hemorheol Microcirc; 2006; 35(4):527-8. PubMed ID: 17148852
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue factor-bearing microparticles and cancer.
    Zwicker JI
    Semin Thromb Hemost; 2008 Mar; 34(2):195-8. PubMed ID: 18645925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet activity in patients with isolated coronary artery ectasia.
    Yasar AS; Erbay AR; Ayaz S; Turhan H; Metin F; Ilkay E; Sabah I
    Coron Artery Dis; 2007 Sep; 18(6):451-4. PubMed ID: 17700216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles.
    Pearson L; Thom J; Adams M; Oostryck R; Krueger R; Yong G; Baker R
    Int J Lab Hematol; 2009 Aug; 31(4):430-9. PubMed ID: 18384393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.